Nature's Sunshine Products, Inc.
Rank #4Capital ReturnNATR · Nasdaq · Consumer Defensive
Nature's Sunshine Products, Inc. (NATR) — Rank #4 by gross profitability (GP/assets 1.34) · ROE 11.5% · Piotroski F-Score N/A.
As-of 2026-09-15 · CIK 0000275053 · all metrics point-in-time as of the filing date.
About
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally.
Show moreShow less
The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate intestinal and digestive functions; personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser. In addition, the company provides weight management products, such as meal replacements and products that increase caloric burn rate. It offers its products under the Nature's Sunshine and Synergy Worldwide brands through its network of independent consultants to customers. Nature's Sunshine Products, Inc.
was founded in 1972 and is headquartered in Lehi, Utah.
- Industry
- Packaged Foods
- Sector
- Consumer Defensive
- State
- UT
- Filer Category
- Accelerated filerSmaller reporting company
- Fiscal Year End
- December 31
- Website
- naturessunshine.com
Price History
Company Snapshot
P/E and reverse DCF are the primary valuation lenses at this stage.
Market Cap
$233.05M
P/E (annual)
12.5
P/S (annual)
0.5
P/B
1.4
P/OCF (annual)
6.6
Shareholder Yield
3.3%
Employees
806
Industry
Packaged Foods
Exchange
Nasdaq
Signal Flags
Quality Profile
Profitability
1/1 passSafety
1/1 passCash Flow
3/3 passGrowth
2/2 passTerry Smith quality gate
Passes 2/5 Terry Smith thresholds1 of 5 threshold not computable from filed data.
What Growth Is Priced In
Implied revenue growth (10Y)
-4.2%
The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).
Buyback tailwind: -3.3% — per-share value needs a total required return of -7.5% once share-count change is priced in.
vs. own 6-year median revenue growth: 5.6%
within its own historyCost-of-equity sensitivity (implied growth at different discount rates)
r = 8%
-7.8%
r = 10% (base)
-4.2%
r = 12%
-1.1%
Net debt / market cap: -33.7%
Valuation History
Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.
P / E
Price / diluted EPS
P / S
Price / revenue per share
P / B
Price / book value per share
P / GP
Price / gross profit per share
P / FCF
Price / free cash flow per share
FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.
Profitability
Gross profitability (GP / assets)
1.34
Primary signal (Novy-Marx).
1st of 9 SIC 2834 peers
Return on equity
11.5%
Gross margin
72.4%
7th of 9 SIC 2834 peers
Revenue growth (YoY)
5.7%
Gross margin improving
Margin trend vs prior year.
Operating Leverage
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue vs COGS | ||||
| Revenue vs OpEx | ||||
| Op. Income vs Revenue |
Growth
Revenue CAGR (3Y)
4.4%
Revenue CAGR (5Y)
4.5%
Earnings CAGR (3Y)
—
FCF CAGR (3Y)
—
Anti-fragile safety
Balance-sheet safety
Composite anti-fragile check.
Debt / equity
0.53
4th of 9 SIC 2834 peers (best = lowest)
Current ratio
2.60×
5th of 9 SIC 2834 peers
Quick ratio
1.40×
Net cash
$82.50M
Cash & equivalents minus total debt.
Cash-flow health
Free cash flow
$28.84M
Operating cash flow minus capex.
Positive free cash flow
FCF / net income
0.48
Cash-backing of earnings.
FCF/NI divergence
Unfavorable divergence (yellow flag).
Accruals healthy
Cash-backed earnings.
SBC / revenue
1.2%
Stock-based comp intensity.
Piotroski F-Score
F-Score
N/A
Only 8/9 components determinable.